HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Recruiting · NCT06731504 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Early phase 1 | 2026-01-16 | NCT06731504 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University Health System | Durham | United States | 15 |